Recurrent Gastric Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment
NCT00028535Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsTreatment